Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center
- PMID: 23578009
- PMCID: PMC4977094
- DOI: 10.1111/acer.12117
Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center
Abstract
Background: Many concerns about liver transplantation in alcoholic patients are related to the risk of alcohol recidivism. Starting from 2002, an Alcohol Addiction Unit (AAU) was formed within the liver transplant center for the management of alcoholic patients affected by end-stage liver disease and included in the waiting list for transplantation. We evaluated retrospectively the impact of the AAU on alcohol recidivism after transplantation. The relationship between alcohol recidivism and the duration of alcohol abstinence before transplant was evaluated as well.
Methods: Between 1995 and 2010, 92 cirrhotic alcoholic patients underwent liver transplantation. Clinical evaluation and management of alcohol use in these patients was provided by psychiatrists with expertise in addiction medicine not affiliated to the liver transplant center before 2002 (n = 37; group A), or by the clinical staff of the AAU within the liver transplant center starting from 2002 (n = 55; group B).
Results: Group B, as compared with group A, showed a significantly lower prevalence of alcohol recidivism (16.4 vs. 35.1%; p = 0.038) and a significantly lower mortality (14.5 vs. 37.8%; p = 0.01). Furthermore, an analysis of group B patients with either ≥6 or <6 months of alcohol abstinence before transplantation showed no difference in the rate of alcohol recidivism (21.1 vs. 15.4%; p = ns).
Conclusions: The presence of an AAU within a liver transplant center reduces the risk of alcohol recidivism after transplantation. A pretransplant abstinence period <6 months might be considered, at least in selected patients managed by an AAU.
Keywords: Alcohol Addiction Unit; Alcohol Dependence; Alcohol Recidivism; Alcoholism; Orthotopic Liver Transplantation.
Copyright © 2013 by the Research Society on Alcoholism.
Conflict of interest statement
Figures




Comment in
-
Liver transplantation in alcoholic patients--reply.Alcohol Clin Exp Res. 2014 Jun;38(6):1799. doi: 10.1111/acer.12241. Epub 2013 Aug 16. Alcohol Clin Exp Res. 2014. PMID: 23952179 No abstract available.
-
Liver transplantation in alcoholic patients.Alcohol Clin Exp Res. 2014 Jun;38(6):1800-2. doi: 10.1111/acer.12242. Epub 2013 Aug 19. Alcohol Clin Exp Res. 2014. PMID: 24033401 No abstract available.
References
-
- Addolorato G, Caputo F, Capristo E, Domenicali M, Bernardi M, Janiri L, Agabio R, Colombo G, Gessa GL, Gasbarrini G. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol Alcohol. 2002;37:504–508. - PubMed
-
- Addolorato G, Abenavoli L, Leggio L, Gasbarrini G. How many cravings? Pharmacological aspects of craving treatment in alcohol addiction: a review. Neuropsychobiol. 2005;51:59–66. - PubMed
-
- Addolorato G, Leggio L, Ferrulli A, Cardone S, Vonghia L, Mirijello A, Abenavoli L, D’Angelo C, Caputo F, Zambon A, Haber PS, Gasbarrini G. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet. 2007;370:1915–1922. - PubMed
-
- Björnsson E, Olsson J, Rydell A, Fredriksson K, Eriksson C, Sjöberg C, Olausson M, Bäckman L, Castedal M, Friman S. Long-term follow-up of patients with alcoholic liver disease after liver transplantation in Sweden: impact of structured management on recidivism. Scand J Gastroenterol. 2005;40:206–216. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous